Aevi Genomic Medicine Inc. (GNMX) Fell -5.23% or -0.09 To Price $1.69 On Monday


Aevi Genomic Medicine Inc. (GNMX) fell -5.23% or -0.09 to $1.69. It is approximately 55788 shares traded, which is 55.52% compare to the average total volume 100478. The market cap of GNMX is $100.10 million. The year to date change is 43.55%. The 52 week price range is from $0.98 to $2.65. Price of GNMX have changed -2.20% during last week. It have changed -12.75% over last month, 42.40% over last 3 months, 43.55% over last 6 months and 0.56% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 2.04. It is 20.71% above current price. The 200-day Moving Averages for GNMX is 1.52. It is -10.06% below current price. The 52-week High is 2.65. It is 56.80% from the current price. The 52-week Low is 0.98. It is -42.01% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNMX is 3.87 on 2018-03-29. Short % to float is 0.80%. There are some statistics of GNMX. It is has market cap $100.10 million. The share outstanding is 59.34 million. The average volume is 100478. The percent of top 15 Institution holding is 47.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -105.84%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -92.17%.


Tags:

Share this post